Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure

Journal of Pediatrics

Volumn 128, Issue 3, 1996, Pages 422-428

  Moler, F W ^a   Steinhart, C M ^a   Ohmit, S E ^a   Stidham, G L ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

AEROSOL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFANT DISEASE; INFANT MORTALITY; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; INTUBATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0029870386     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70294-9     Document Type: Article

References (49)

1. American Academy of Pediatrics Committee on Infectious Disease Use of ribavirin in the treatment of respiratory syncytial virus infection Pediatrics 92 1993 501 504
2. ER Wald B. Dashepsky Ribavirin: Red Book Committee recommendations questioned Pediatrics 93 1994 672 673 [Commentary]
3. FW Moler KP Bandy JR. Custer A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection N Engl J Med 325 1991 1884 1885 [Letter]
4. BJ. Sullivan A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection N Engl J Med 325 1991 1885 [Letter]
5. VL Ackerman PS Salva Bronchiolitis GM Loughlin H Eigen Respiratory disease in children 1994 Willams & Wilkins Baltimore 296 298
6. S Ito G. Koren Exposure of pregnant women to ribavirin-contaminated air: risk assessment and recommendations Pediatr Infect Dis J 12 1993 2 5
7. D. Isaacs Ribavirin Pediatrics 79 1987 289 291 [Commentary]
8. GC. Ray Ribavirin: ambivalence about an antiviral agent Arch Pediatr Adolesc Med [Am J Dis Child] 142 1988 488 489 [Editorial]
9. M Sharland N Whitehouse S. Qureshi Ribavirin in respiratory syncytial virus infection Arch Dis Child 64 1989 425 [Letter]
10. MM. Pollack An R.S.V.P. to R.S.V. (respiratory syncytial virus): declining mortality rates Crit Care Med 20 1992 1375 1376
11. B Krafte-Jacobs PR. Holbrood Ribavirin in severe respiratory syncytial virus infection Crit Care Med 22 1994 541 543 [Editorial]
12. AR. Zucker Red Book recommendations on ribavirin challenged Pediatrics 93 1994 872 873 [Letter]
13. RB. Turner Red Book recommendations on ribavirin challenged Pediatrics 93 1994 873 [Letter]
14. JF Pope JB Besunder ML Kumar DM. Super Concerned about ribavirin recommendation Pediatrics 94 1994 132 133 [Letter]
15. I Mitchell A Joffe CJL. Newth Ribavirin: Red Book Committee recommendations questioned [Letter] Pediatrics 95 1995 319 320
16. American Academy of Pediatrics Committee on Infectious Disease Use of ribavirin in the treatment of respiratory syncytial virus infection Pediatrics 79 1987 475 476
17. DW Smith LR Frankel LH Mathers AT Tang RL Adriagno CG. Prober A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection N Engl J Med 325 1991 24 29
18. ML Lebel M Gauthier J Lacroix E Rousseau M. Buithieu Respiratory failure and mechanical ventilation in severe bronchiolitis Arch Dis Child 64 1989 1431 1437
19. KM Outwater RK. Crone Management of respiratory failure in infants with acute viral bronchiolitis Arch Pediatr Adolesc Med [Am J Dis Child] 138 1984 1071 1075
20. M Stretton SJ Ajizian I Mitchell CJL. Newth Intensive care course and outcome of patients infected with respiratory syncytial virus Pediatr Pulmonol 13 1992 143 150
21. F Moler A Khan J. Custer Mechanical ventilation for RSV infection: does ribavirin improve patient morbidity? Crit Care Med 20 1992 S87
22. KL Meert AP Sarniak MJ Gelmini MW. Lieh-Lai Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial Crit Care Med 22 1994 566 572
23. MM Pollack RW Katz UE Ruttimann PR. Getson Improving the outcome and efficiency of intensive care: the impact of an intensivist Crit Care Med 16 1988 11 17
24. 12th ed MG Greene The Harriet Lane Handbook 1991 Mosby–Year Book St. Louis
25. MM Pollack UE Ruttimann PR. Getson Pediatric risk of mortality (PRISM) score Crit Care Med 16 1988 1110 1116
26. BJ Law V De Carvalho Pediatric Investigators Collaborative Network on Infections in Canada Pediatr Infect Dis J 12 1993 659 663
27. EE Wang BJ Law D Stephens other members of PICNIC Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) propective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection J PEDIATR 126 1995 212 219
28. NE MacDonald CB Hall SC Suffin C Alexson PJ Harris JA. Manning Respiratory syncytial viral infection in infants with congenital heart disease N Engl J Med 307 1982 397 400
29. WJ Rodriguez HW Kim CD Brant Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus infection Pediatr Infect Dis 6 1987 159 163
30. LH Taber V Knight BE Gilbert Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants Pediatrics 72 1983 613 618
31. CB Hall JT McBride EE Walsh Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized, double-blind study N Engl J Med 308 1983 1443 1447
32. W Barry F Cockburn R Cornall JF Price G Sutherland A. Vardag Ribavirin aerosol for acute bronchiolitis Arch Dis Child 61 1986 593 597
33. GH Guyatt DL Sackett DJ Cook for the Evidence-Based Medicine Working Group User's guide to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? JAMA 271 1994 59 63
34. JR Groothuis KM Gutierrez BA. Laven Respiratory syncytial virus infection in children with bronchopulmonary dysplasia Pediatrics 82 1988 199 203
35. HK Janai HR Stutman M Zaleska Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus Pediatr Infect Dis J 12 1993 214 218
36. JG Wheeler J Wofford RB. Turner Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection Pediatr Infect Dis J 12 1993 209 213
37. BA Law EE Wang D Stephens members of the Pediatric Investigators Collaborative Network on Infections in Canada PICNIC Ribavirin does not reduce hospital stay (LOS) in patients with respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) Pediatr Res 37 1995 110A [Abstract]
38. SE. Ohmit Epidemiology and natural history of respiratory syncytial virus in hospitalized children: an evaluation of ribavirin utilization and effectiveness 1993 University of Michigan Ann Arbor [Dissertation]
39. L Navas E Wang V Carvalho Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canada J PEDIATR 121 1992 348 354
40. FW Moler AS Khan JN Meliones JR Custer J Palmisano TC. Shope Respiratory syncytial virus morbidity and mortality in congenital heart disease patients: a recent experience Crit Care Med 10 1992 1406 1413
41. CM Smith SD. Anderson Inhalation provocation tests using nonisotonic aerosols J Allergy Clin Immunol 84 1989 781 790
42. RE Schoffell AD Anderson RE. Altountan Bronchial hyperreactivity in response to inhalation of ultrasonically nebulized solutions of distilled water and saline BMJ 283 1981 1285 1287
43. Medical treatment effectiveness research. II. National Institutes of Health guide to grants and contracts vol 22 July 16, 1993 U.S. Public Health Service Rockville, Maryland No. 25. (Publication No. RFA: HS-94-002.)
44. DG Kleinbaum LL Kupper H. Morgenstern Epidemiologic research: principles and quantitative methods 1982 Van Nostrand Reinhold New York 62 65
45. AR. Feinstein An additional basic science for clinical medicine: II. The limitations of randomized clinical trials Ann Intern Med 99 1983 544 550
46. Methodologic issues in measuring patient-reported outcomes: the agenda of the Work Group on Outcomes Assessment Med Care 32 1994 JS65 JS76 (suppl)
47. Agency for Health Care Policy and Research Program note: Study of patient outcomes associated with pharmaceutical therapy March 1992 U.S. Public Health Service Rockville, Maryland (Publication No. RFA: HS-92-03)
48. Medical treatment effectiveness research National Institutes of Health guide vol 23 June 19, 1994 U.S. Public Health Service Rockville, Maryland [Summary] No. 22. (Publication No. PPA-94-074.)
49. K Meert S Heidemann B Abella A. Sarnaik Does prematurity alter the course of respiratory syncytial virus infection? Crit Care Med 18 1990 1357 1359